Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome

https://www.globenewswire.com/news-release/2021/08/19/2283569/0/en/Zealand-Pharma-Announces-First-Patient-Dosed-in-EASE-SBS-4-Phase-3b-Trial-Assessing-Glepaglutide-in-Patients-with-Short-Bowel-Syndrome.html

press release